对新表位预测的系统评估挑战了临床观察到的T细胞反应及其对免疫逃避的影响
Badeel Kh Q Zaghla1, Zuhal Safyürek1, Daniela Gröger1
1Department of Hematology, Oncology and Tumor Immunology, Hindenburgdamm 30, 12203 Berlin, Germany, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, BE, Germany.
Journal for immunotherapy of cancer
|January 8, 2026
概括
对人类白细胞抗原 (HLA) 呈现的实验验证显示,预测的新抗原中只有22%的呈现成功. 这一发现挑战了以前关于癌症免疫力和免疫逃生机制的假设.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 生物化学 生物化学
背景情况:
- 人类白细胞抗原 (HLA) 的体呈现对T细胞反应至关重要,影响抗癌免疫力和免疫逃逸.
- 通常使用in silico预测工具,但缺乏对HLA呈现的实验验证.
研究的目的:
- 通过实验验证HLA类I等位基因呈现的新抗原.
- 评估HLA呈现的in silico预测工具的准确性.
- 重新评估新抗原呈现的下游影响,包括免疫逃脱和疫苗疗效.
主要方法:
- 过度表达125个新抗原/HLA I类等位基因组合.
- 实验验证使用HLA连体隔离和联质谱.
- 对个性化mRNA新型细胞组疫苗序列和T细胞受体克隆的分析.
主要成果:
- 只有22%的预测新抗原呈现得到实验验证.
- 在58%的病例中,HLA异构性丧失和预测的新表位体之间的关联受到质疑.
- 对个性化mRNA新表位素疫苗的临床反应独立于新表位素呈现状态.
结论:
- 对新抗原呈现的实验验证对于准确解释癌症免疫和免疫逃生至关重要.
- 目前的in silico预测方法高估了新抗原呈现频率.
- 这些发现需要对基于新抗原的癌症疗法和疫苗的策略进行重新评估.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


